We are live on ! Find out more
ZNTL icon

Zentalis Pharmaceuticals
ZNTL

107 hedge funds and large institutions have $1.94B invested in Zentalis Pharmaceuticals in 2020 Q4 according to their latest regulatory filings, with 47 funds opening new positions, 41 increasing their positions, 13 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

840% more first-time investments, than exits

New positions opened: 47 | Existing positions closed: 5

215% more repeat investments, than reductions

Existing positions increased: 41 | Existing positions reduced: 13

85% more capital invested

Capital invested by funds: $1.05B → $1.94B (+$889M)

62% more funds holding

Funds holding: 66 → 107 (+41)

11.65% more ownership

Funds ownership: 80.2% → 91.85% (+12%)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

Holders
107
Holders Change
+41
Holders Change %
+62.12%
% of All Funds
1.89%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
47
Increased
41
Reduced
13
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$146M
2
BlackRock
BlackRock
New York
+$59.3M
3
Vanguard Group
Vanguard Group
Pennsylvania
+$54.7M
4
State Street
State Street
Massachusetts
+$32.9M
5
APM
Avidity Partners Management
Texas
+$10.4M

Top Sellers

Rank Fund Capital Flow
1
Viking Global Investors
Viking Global Investors
Connecticut
-$64.6M
2
FCM
Farallon Capital Management
California
-$32.4M
3
SAM
Sectoral Asset Management
Quebec, Canada
-$18.2M
4
Citadel Advisors
Citadel Advisors
Florida
-$8.38M
5
MC
Mayo Clinic
Minnesota
-$3.62M
Name Holding Trade Value Shares
Change 		Change in
Stake
Axa
26
Axa
France
$8.36M +$220K +4,883 +3%
WP
27
Woodline Partners
California
$7.27M +$95.4K +2,116 +2%
CCM
28
CAAS Capital Management
New York
$6.89M +$2.95M +65,311 +97%
Charles Schwab
29
Charles Schwab
California
$6.47M +$1.71M +37,817 +44%
DCM
30
Driehaus Capital Management
Illinois
$6.15M +$5.34M +118,424 New
N
31
Nuveen
North Carolina
$5.5M +$2.95M +65,359 +161%
Morgan Stanley
32
Morgan Stanley
New York
$5.24M +$4.21M +93,346 +1,232%
GLA
33
Great Lakes Advisors
Illinois
$5.21M +$4.53M +100,335 New
Bank of New York Mellon
34
Bank of New York Mellon
New York
$5.02M +$2.86M +63,303 +190%
California Public Employees Retirement System
35
California Public Employees Retirement System
California
$3.31M +$1.69M +37,449 +143%
MWNA
36
Marshall Wace North America
New York
$3.1M – – –
Two Sigma Investments
37
Two Sigma Investments
New York
$2.96M +$2.57M +57,031 New
Bank of America
38
Bank of America
North Carolina
$2.5M +$818K +18,132 +61%
D.E. Shaw & Co
39
D.E. Shaw & Co
New York
$2.35M +$1.68M +37,294 +467%
PCM
40
Pentwater Capital Management
Florida
$2.34M -$226K -5,000 -10%
California State Teachers Retirement System (CalSTRS)
41
California State Teachers Retirement System (CalSTRS)
California
$2.26M +$1.17M +26,036 +149%
Swiss National Bank
42
Swiss National Bank
Switzerland
$2.11M +$1.84M +40,700 New
State of Wisconsin Investment Board
43
State of Wisconsin Investment Board
Wisconsin
$2.08M +$1.06M +23,500 +142%
RhumbLine Advisers
44
RhumbLine Advisers
Massachusetts
$1.69M +$918K +20,347 +168%
CS
45
Credit Suisse
Switzerland
$1.63M +$1.42M +31,374 New
Allianz Asset Management
46
Allianz Asset Management
Germany
$1.4M – – –
New York State Common Retirement Fund
47
New York State Common Retirement Fund
New York
$1.3M +$704K +15,600 +164%
TD Asset Management
48
TD Asset Management
Ontario, Canada
$1.27M +$90.2K +2,000 +9%
Deutsche Bank
49
Deutsche Bank
Germany
$1.21M +$772K +17,122 +274%
Russell Investments Group
50
Russell Investments Group
United Kingdom
$1.21M +$1.05M +23,336 New
1
2
3 4 5

ZNTL Hedge Fund Activity: Q4 2020 in Review

107 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Zentalis Pharmaceuticals (ZNTL) for Q4 2020, worth a combined $1.94B — up 85% from $1.05B a quarter earlier.

Buyers outnumbered sellers: 47 funds opened new ZNTL positions and 5 closed out — a net gain of 42 holders — while 41 added to existing stakes and 13 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $146M. The largest seller was Viking Global Investors, cutting an estimated $64.6M.

  • 107 institutional investors held Zentalis Pharmaceuticals (ZNTL) as of Q4 2020, up from 66 in Q3 2020.
  • Funds reported $1.94B of Zentalis Pharmaceuticals stock for Q4 2020, up 85% quarter-over-quarter.
  • 47 funds opened new Zentalis Pharmaceuticals positions in Q4 2020 and 5 closed out, a net change of +42 holders.
  • The largest Zentalis Pharmaceuticals buyer in Q4 2020 was Fidelity Investments, an estimated $146M added.
  • The largest Zentalis Pharmaceuticals seller in Q4 2020 was Viking Global Investors, an estimated $64.6M sold.

Based on aggregated 13F filings for Q4 2020.